Literature DB >> 21088871

Endogenous ADP-ribosylation of elongation factor-2 by interleukin-1β.

Doris Jäger1, Karl Werdan, Ursula Müller-Werdan.   

Abstract

Eukaryotic elongation factor-2 (eEF-2) catalyses the motion of the growing peptide chain relative to the mRNA at the ribosomes during protein synthesis. This highly conserved G-protein is the specific target of two lethal bacterial toxins, Pseudomonas aeruginosa exotoxin A and diphtheria toxin. These toxins exert their detrimental action by ADP-ribosylating a biologically unique posttranslationally modified histidine residue (diphthamide(715)) within eEF-2, thus inactivating the enzyme. Diphthamide(715) is also the target of endogenous (mono) ADP-ribosyl transferase activity. In this article, we report the first known activator of endogenous ADP-ribosylation of eEF-2, interleukin-1β (IL-1β). Thereby, systemic inflammatory processes may link to protein synthesis regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088871     DOI: 10.1007/s11010-010-0646-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  16 in total

1.  NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.

Authors:  B H Iglewski; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Preparation and culture of embryonic and neonatal heart muscle cells: modification of transport activity.

Authors:  K Werdan; E Erdmann
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

3.  Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells.

Authors:  K Pönicke; I Heinroth-Hoffmann; K Becker; O E Brodde
Journal:  Br J Pharmacol       Date:  1997-05       Impact factor: 8.739

Review 4.  Peptide-chain elongation in eukaryotes.

Authors:  C G Proud
Journal:  Mol Biol Rep       Date:  1994-05       Impact factor: 2.316

5.  Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha.

Authors:  K Isoda; Y Kamezawa; N Tada; M Sato; F Ohsuzu
Journal:  J Card Fail       Date:  2001-12       Impact factor: 5.712

6.  Heterogeneity of cardiac rat and human elongation factor 2.

Authors:  D Jäger; C Seliger; N T Redpath; I Friedrich; R E Silber; K Pönicke; K Werdan; U Müller-Werdan
Journal:  Electrophoresis       Date:  2000-07       Impact factor: 3.535

7.  High-resolution one-dimensional polyacrylamide gel isoelectric focusing of various forms of elongation factor-2.

Authors:  N T Redpath
Journal:  Anal Biochem       Date:  1992-05-01       Impact factor: 3.365

8.  Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2.

Authors:  A C Nairn; H C Palfrey
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

9.  Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.

Authors:  C M Thaik; A Calderone; N Takahashi; W S Colucci
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

Authors:  A Kumar; V Thota; L Dee; J Olson; E Uretz; J E Parrillo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  5 in total

1.  Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin.

Authors:  Laura M Icenogle; Shawna M Hengel; Lisette H Coye; Amber Streifel; Carleen M Collins; David R Goodlett; Steve L Moseley
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

2.  Interleukin-1β effect on the endogenous ADP-ribosylation and phosphorylation of eukaryotic elongation factor 2.

Authors:  Ebru Hacıosmanoğlu; Başak Varol; Bilge Özerman Edis; Muhammet Bektaş
Journal:  Cytotechnology       Date:  2016-08-10       Impact factor: 2.058

Review 3.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

Review 4.  RNA Regulation by Poly(ADP-Ribose) Polymerases.

Authors:  Florian J Bock; Tanya T Todorova; Paul Chang
Journal:  Mol Cell       Date:  2015-06-18       Impact factor: 17.970

Review 5.  The biosynthesis and biological function of diphthamide.

Authors:  Xiaoyang Su; Zhewang Lin; Hening Lin
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-08-23       Impact factor: 8.697

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.